Share Email Print
cover

Proceedings Paper

Copper vapor laser prospects in glaucoma treatment
Author(s): E. A. Egorov; Arcady P. Nesterov; Vladimir I. Novoderezhkin; Alexey E. Egorov; Naim Shaban; Igor V. Ponomarev
Format Member Price Non-Member Price
PDF $17.00 $21.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

New advances of copper vapor laser (CVL-laser) have been studied. Two wavelength radiation of the laser (511 nm and 578 nm) gives deeper permeability into organic tissues. Besides, the short pulse prevents the warm relaxation of small vessels. The technical data of CVL-laser: operating regime -- pulse, pulse duration -- 20 ns, pulse frequency 15000 pulse/sec. The shutter works in intervals from 0.05 to 2.0 sec. The power varies in accordance with wavelength: 511 nm (green) -- 1.5 W, 578 nm (yellow) -- 1, 2 W. The diameter of coagulate may be different: 100, 150, 400, 1000 mkm. We chose CVL-laser 'Femta,' created by P. N. Lebedev Physical Institute of RAS, for ophthalmological use. Thirty eight eyes of 37 patients with different types and stages of glaucoma were studied and treated with CVL-laser. The operations of photomydriasis, gonioplasty and trabeculoplasty have been performed. CVL- laser demonstrated efficient application in treatment of interior eye segment of glaucoma patients. The advantages and disadvantages of the CVL-laser application in glaucoma surgery were discussed.

Paper Details

Date Published: 17 May 1996
PDF: 6 pages
Proc. SPIE 2673, Ophthalmic Technologies VI, (17 May 1996); doi: 10.1117/12.240074
Show Author Affiliations
E. A. Egorov, Russian State Medical Univ. (Russia)
Arcady P. Nesterov, Russian State Medical Univ. (Russia)
Vladimir I. Novoderezhkin, Russian State Medical Univ. (Russia)
Alexey E. Egorov, Russian State Medical Univ. (Russia)
Naim Shaban, Russian State Medical Univ. (Russia)
Igor V. Ponomarev, P.N. Lebedev Physical Institute (Russia)


Published in SPIE Proceedings Vol. 2673:
Ophthalmic Technologies VI
Jean-Marie A. Parel; Karen Margaret Joos M.D.; Pascal O. Rol, Editor(s)

© SPIE. Terms of Use
Back to Top